sgi-110
Showing 1 - 8 of 8
Metastatic Colorectal Cancer Trial in Baltimore (CY, GVAX, SGI-110)
Completed
- Metastatic Colorectal Cancer
- CY
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 26, 2021
MDS, CMML, AML Trial in Canada, United States (SGI-110)
Completed
- MDS
- +2 more
- SGI-110
-
Scottsdale, Arizona
- +15 more
Apr 16, 2021
Previously Treated Metastatic Colorectal Cancer Trial in Netherlands, United States (SGI-110 Dose Escalation, Regorafenib,
Completed
- Previously Treated Metastatic Colorectal Cancer
- SGI-110 Dose Escalation
- +4 more
-
Los Angeles, California
- +3 more
Sep 14, 2020
Extensive-stage Small Cell Lung Cancer Trial in New York (Durvalumab, Tremelimumab, SGI-110)
Completed
- Extensive-stage Small Cell Lung Cancer
- Durvalumab
- +2 more
-
New York, New YorkColumbia University Medical Center
Dec 7, 2018
Metastatic Melanoma Trial in Siena (SGI-110, Ipilimumab)
Unknown status
- Metastatic Melanoma
- SGI-110
- Ipilimumab
-
Siena, ItalyMedical Oncology and Immunotherapy Unit, University Hospital of
Nov 16, 2015